Turnstone Biologics Corp (TSBX)

Nov 5, 2024, 9:01 AM EST - 2 months ago

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Aug 15, 2024, 11:57 AM EDT - 5 months ago

Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study

Aug 14, 2024, 4:05 PM EDT - 5 months ago

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

Aug 14, 2024, 4:01 PM EDT - 5 months ago

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer

May 13, 2024, 5:01 PM EDT - 8 months ago

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

May 8, 2024, 9:00 AM EDT - 9 months ago

Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference

Apr 16, 2024, 9:00 AM EDT - 9 months ago

Turnstone Biologics Appoints William Waddill to its Board of Directors

Mar 21, 2024, 5:06 PM EDT - 10 months ago

Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights

Feb 21, 2024, 6:00 AM EST - 11 months ago

Turnstone Biologics to Participate in Upcoming Investor Conferences

Feb 20, 2024, 5:00 PM EST - 11 months ago

Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.

Nov 27, 2023, 6:00 AM EST - 1 year ago

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nov 9, 2023, 9:49 PM EST - 1 year ago

Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights

Nov 3, 2023, 6:00 AM EDT - 1 year ago

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 30, 2023, 6:00 AM EDT - 1 year ago

Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber

Sep 28, 2023, 6:00 AM EDT - 1 year ago

Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting

Sep 21, 2023, 5:11 AM EDT - 1 year ago

Top 4 Health Care Stocks That Could Lead To Your Biggest Gains In Q3

SCLX SGHT TNYA

Sep 1, 2023, 5:57 PM EDT - 1 year ago

Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update

Jul 27, 2023, 4:36 PM EDT - 1 year ago

FMR LLC Acquires Significant Stake in Turnstone Biologics Corp

Jul 21, 2023, 8:20 AM EDT - 1 year ago

Turnstone Biologics set to go public as upsized $80 million IPO pricing at low end of expected range

Jul 21, 2023, 2:15 AM EDT - 1 year ago

Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering

Jul 17, 2023, 3:06 PM EDT - 1 year ago

IPO Update: Turnstone Biologics Readies $75 Million IPO Plan

Jul 17, 2023, 6:35 AM EDT - 1 year ago

Turnstone Biologics to offer 5.8 million shares in planned IPO priced at $12 to $14 each

Jun 14, 2023, 4:27 PM EDT - 1 year ago

Turnstone Biologics Begins $86 Million U.S. IPO Plan